These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3422419)

  • 21. Autoimmune Hemorrhaphilia Resulting from Autoantibody against the A Subunit of Factor XIII.
    Uchida E; Watanabe K; Arai R; Yamamoto M; Souri M; Osaki T; Ichinose A; Miura O; Koyama T
    Intern Med; 2015; 54(18):2383-7. PubMed ID: 26370866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
    Ueno S; Nozaki J; Kusano S; Kawano Y; Kikukawa Y; Okuno Y; Hata H; Matsuoka M; Uchiba M
    Rinsho Ketsueki; 2019; 60(10):1443-1448. PubMed ID: 31695005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
    Ichinose A;
    Blood Rev; 2017 Jan; 31(1):37-45. PubMed ID: 27542511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.
    Milner GR; Holt PJ; Bottomley J; Maciver JE
    J Clin Pathol; 1977 Aug; 30(8):770-3. PubMed ID: 599192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination.
    Luo YY; Zhang GS
    Haemophilia; 2011 May; 17(3):393-8. PubMed ID: 21323797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström's macroglobulinemia.
    Krumdieck R; Shaw DR; Huang ST; Poon MC; Rustagi PK
    Am J Med; 1991 May; 90(5):639-45. PubMed ID: 1903026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW; Haverkate F; Koopman J; Nieuwenhuis HK; Kluft C; Boschman TA
    Thromb Haemost; 1987 Apr; 57(2):171-5. PubMed ID: 2440124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracerebral haemorrhage due to acquired factor XIII inhibitor--successful response to factor XIII concentrate.
    Daly HM; Carson PJ; Smith JK
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):507-14. PubMed ID: 1768763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.
    Tone KJ; James TE; Fergusson DA; Tinmouth A; Tay J; Avey MT; Kilty S; Lalu MM
    Transfus Med Rev; 2016 Jul; 30(3):123-31. PubMed ID: 27167905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
    Sié P; Bezeaud A; Dupouy D; Archipoff G; Freyssinet JM; Dugoujon JM; Serre G; Guillin MC; Boneu B
    J Clin Invest; 1991 Jul; 88(1):290-6. PubMed ID: 1711542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An acquired inhibitor to factor XIII A case report.
    Shires L; Gomperts ED; Bradlow BA
    S Afr Med J; 1979 Jul; 56(2):70-2. PubMed ID: 483113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab).
    Souri M; Mokuda S; Inanami H; Osaki T; Takasugi K; Ichinose A
    Thromb Res; 2016 Apr; 140():100-105. PubMed ID: 26938156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Presence of a plasma antigen indispensable to the stabilization of fibrin in 2 cases on congenital factor XIII deficiency].
    Soria J; Soria C; Samama M; Josso F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):356-60. PubMed ID: 5511868
    [No Abstract]   [Full Text] [Related]  

  • 35. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
    Ishida F; Okubo K; Ito T; Okumura N; Souri M; Ichinose A
    Thromb Haemost; 2010 Dec; 104(6):1284-5. PubMed ID: 20941461
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acquired inhibitor to factor XIII.
    McDevitt NB; McDonagh J; Taylor HL; Roberts HR
    Arch Intern Med; 1972 Nov; 130(5):772-7. PubMed ID: 5083419
    [No Abstract]   [Full Text] [Related]  

  • 38. A naturally occurring antibody that inhibits fibrin polymerization.
    Hoots WK; Carrell NA; Wagner RH; Cooper HA; McDonagh J
    N Engl J Med; 1981 Apr; 304(15):857-61. PubMed ID: 7207522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An acquired coagulation inhibitor to factor II.
    Scully MF; Ellis V; Kakkar VV; Savidge GF; Williams YF; Sterndale H
    Br J Haematol; 1982 Apr; 50(4):655-64. PubMed ID: 7066212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.